Stifel Nicolaus Downgrades InterMune To Hold
Analysts at Stifel Nicolaus downgraded InterMune (NASDAQ: ITMN) from Buy to Hold and removed the price target of
InterMune shares have surged 262.29% over the past 52 weeks, while the S&P 500 index has gained 20.02% in the same period.
InterMune's shares surged 35.82% to $73.07 in pre-market trading.
Latest Ratings for ITMN
|Aug 2014||Cowen & Company||Initiates Coverage on||Market Perform|
|Aug 2014||JMP Securities||Downgrades||Market Outperform||Market Perform|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.